<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id><journal-id journal-id-type="pmc-domain-id">63</journal-id><journal-id journal-id-type="pmc-domain">bmcph</journal-id><journal-title-group><journal-title>BMC Public Health</journal-title></journal-title-group><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10898104</article-id><article-id pub-id-type="pmcid-ver">PMC10898104.1</article-id><article-id pub-id-type="pmcaid">10898104</article-id><article-id pub-id-type="pmcaiid">10898104</article-id><article-id pub-id-type="pmid">38408965</article-id><article-id pub-id-type="doi">10.1186/s12889-024-18115-7</article-id><article-id pub-id-type="publisher-id">18115</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association of the blood levels of specific volatile organic compounds with nonfatal cardio-cerebrovascular events in US adults</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Jing</surname><given-names initials="L">Li</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Chen</surname><given-names initials="T">Tiancong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Z">Zhiyong</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Dong</surname><given-names initials="W">Weiwei</given-names></name><address><email>dongww@sj-hospital.org</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412467.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1806 3501</institution-id><institution>Department of Nursing, </institution><institution>Shengjing Hospital of China Medical University, </institution></institution-wrap>Shenyang, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412467.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1806 3501</institution-id><institution>Department of Neurosurgery, </institution><institution>Shengjing Hospital of China Medical University, </institution></institution-wrap>Shenyang, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.412467.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1806 3501</institution-id><institution>Department of Cardiology, </institution><institution>Shengjing Hospital of China Medical University, </institution></institution-wrap>Shenyang, China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>2</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>24</volume><issue-id pub-id-type="pmc-issue-id">452043</issue-id><elocation-id>616</elocation-id><history><date date-type="received"><day>28</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>27</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-26 14:25:36.953"><day>26</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12889_2024_Article_18115.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Cardio-cerebrovascular diseases constitute a major global public health burden. Volatile organic compounds (VOCs) exposure has become progressively severe, endangering human health and becoming one of the main concerns in environmental pollution. The associations of VOCs exposure with nonfatal cardio-cerebrovascular events have not been identified in observational study with a large sample size, so we aim to examine the association in US adult population.</p></sec><sec><title>Methods</title><p id="Par2">Adults aged&#8201;&gt;&#8201;18 years with complete data regarding selected blood levels of VOCs (including benzene, ethylbenzene, o-xylene, and m-/p-xylene) and nonfatal cardio-cerebrovascular events were included in the analysis (<italic toggle="yes">n</italic>&#8201;=&#8201;3,968, National Health and Nutrition Examination Survey, NHANES, 2013&#8211;2018 survey cycle). Participants were classified into low- and high-exposure based on whether above selected VOCs low limit detect concentration or median value. Weighted multivariate logistic analyses and subgroup analyses were used to detect the association between selected VOCs exposure and nonfatal cardio-cerebrovascular events in US adults.</p></sec><sec><title>Results</title><p id="Par3">Weighted multivariate logistic analyses showed that the high-VOCs exposure group had an increased risk of nonfatal cardio-cerebrovascular events compared with the low-VOCs exposure group; the adjusted odds ratios (OR) and 95% confidence intervals (CI) of nonfatal cardio-cerebrovascular events for the high-VOCs exposure group were 1.41 (0.91, 2.19), 1.37 (0.96, 1.95), 1.32 (0.96, 1.82), and 1.17 (0.82, 1.67) for benzene, ethylbenzene, o-xylene, and m-/p-xylene, respectively, which was not significant assuming statistical significance at a 0.05 significance level (95% CI) for a two-tailed test. Lastly, we found high-VOCs exposure was associated with increased incidence of nonfatal cardio-cerebrovascular events in both daily smokers an non-daily smokers (<italic toggle="yes">p-</italic>interaction&#8201;&gt;&#8201;0.01), but the association was not statistically significant in non-daily smokers.</p></sec><sec><title>Conclusions</title><p id="Par4">This study found that VOCs (benzene, ethylbenzene, o-xylene, and m-/p-xylene) exposure was associated with increased incidence of nonfatal cardio-cerebrovascular events in US adults, and the results need to be confirmed by larger cohort studies.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12889-024-18115-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>VOCs</kwd><kwd>Myocardial infarction</kwd><kwd>Stroke</kwd><kwd>NHANES</kwd><kwd>Cross-sectional study</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Globally, cardio-cerebrovascular diseases are the major causes of mortality and disability in the US despite increased preventive efforts [<xref ref-type="bibr" rid="CR1">1</xref>]. Cardiovascular diseases account for 34% of all deaths in the US, with annual costs exceeding $500&#160;billion [<xref ref-type="bibr" rid="CR2">2</xref>]. Cardio-cerebrovascular disorders pose a great challenge to global health and economic burdens [<xref ref-type="bibr" rid="CR3">3</xref>]. Further, cardio-cerebrovascular diseases remain an important threat to human health under conditions of increasing environmental pollution. It is important to identify environmental pollutant risk factors for cardio-cerebrovascular diseases as a complementary strategy for the prevention of cardio-cerebrovascular diseases [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par6">The correlation between volatile organic compounds (VOCs) exposure and cardio-cerebrovascular disease has received more attention in recent years [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>]. VOCs are considered to be risk factors for hypertension, endothelial injury, and cardiovascular events [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]. VOCs exposure is correlated with increasing risk of heart disease-related death, with a hazard ratio and 95% confidence interval of 1.39 (1.09&#8211;1.77) [<xref ref-type="bibr" rid="CR13">13</xref>]. The four compounds in VOCs, including benzene, toluene, ethylbenzene, o-xylene, and m-/p-xylene, are collectively referred as BTEXs, and often analyzed together. Environmental and occupational pollution caused by VOCs is widespread from substances including tobacco smoke, paints, motor vehicle exhausts, furniture, and building materials [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. VOCs can cause non-cancerous health effects in humans even at low exposure levels [<xref ref-type="bibr" rid="CR16">16</xref>]. The majority of studies on VOCs have focused on occupational exposures and had small sample size and specific exposure conditions. The effects of VOCs on cardio-cerebrovascular systems have rarely been investigated among the general population. The evidence on the association between VOCs exposure and cardio-cerebrovascular disease from well-designed, large-sample studies among the general population is still lacking. Hence, we performed a large cross-sectional investigation to identify the association between VOCs exposure and cardio-cerebrovascular diseases using surveillance data from National Health and Nutrition Examination Survey (NHANES) database. Higher VOCs exposure was hypothesized to be associated with a higher incidence of nonfatal cardio-cerebrovascular events.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Study population</title><p id="Par7">The study data were obtained from the NHANES database, which was established by the Center for Disease Control and Prevention (CDC) to assess the nutritional and health status of the US population. Because multi-stage stratified probability sampling was utilized in the NHANES study design, samples in NHANES are representative of the US population. Details of the NHANES survey and measurement methods are available online (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx).Al">https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx).Al</ext-link>l dataset used in this study was taken from publicly available dataset (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/Default.aspx).Th">https://wwwn.cdc.gov/nchs/nhanes/Default.aspx).Th</ext-link>e CDC provides free access to NHANES data via their official website. Our study included three NHANES survey cycles from 2013 to 2018, containing demographic, examination, laboratory, and questionnaire data. At first, 29,400 participants were enrolled in the study, and we excluded the individuals with missing data on stroke or myocardial infarction status (<italic toggle="yes">n</italic>&#8201;=&#8201;19,941) and blood VOCs (benzene, ethylbenzene, o-xylene, and m-/p-xylene) concentration (<italic toggle="yes">n</italic>&#8201;=&#8201;5491). A final number of 3,968 participants aged &gt;18 years were enrolled in this study. The missing value in laboratory data was imputed via multiple imputation. The National Center for Health Statistics and Research Ethics Review Committee approved the use of human subjects for the NHANES study and written informed consent was provided by each participant.</p></sec><sec id="Sec4"><title>Exposure and outcome definitions</title><p id="Par8">Participants visited a mobile examination clinic (MEC) where blood samples were collected. The vials were preserved under appropriate refrigerated (2&#8211;8&#160;&#176;C) conditions prior to shipment to the National Center for Environmental Health for analysis. Blood VOCs levels were measured via gas chromatography/mass spectrometry with selected-ion monitoring and isotope dilution. With this technique, blood VOCs levels in whole blood can be measured down to low parts per trillion. The NHANES Laboratory Procedures Manual contains detailed guidelines on sample collection and processing. The majority of 32 blood VOCs in NHANES had an extremely low detection rate. Benzene, ethylbenzene, o-xylene, and m-/p-xylene are with relatively higher detection rates approximately 30% and above in 32 blood VOCs and may affect the cardiovascular system, so we chose them for this study. The lowest limits of detectable blood VOCs concentrations and detection rates of selected VOCs in the blood are shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. Blood VOCs concentrations below the limit of detection (LOD) were imputed by dividing the LOD by the square root of 2. To ensure reliable results, we also inputed blood VOCs concentrations below the LOD with 0 and the LOD value. There was no recognized cut point for the VOCs involved in this study, so we referred to the methodology of previous study and classified participants into low- and high-exposure based on whether above their LOD concentration or median value [<xref ref-type="bibr" rid="CR17">17</xref>], as shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par9">We used the Medical Condition Questionnaire to determine outcomes. Our assessment method of defining a person with myocardial infarction or stroke was consistent with our previous studies [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Previous epidemiological research employing NHANES data used these self-reported definitions of stroke and myocardial infarction and demonstrated that the self-reported assessment method was valid [<xref ref-type="bibr" rid="CR20">20</xref>]. Participants self-reported myocardial infarction and/or stroke was used to define the outcome &#8220;nonfatal cardio-cerebrovascular event&#8221;.</p></sec><sec id="Sec5"><title>Covariates</title><p id="Par10">Variables with a possible effect on the association of blood VOCs levels with nonfatal cardio-cerebrovascular events were gathered for this investigation based on the clinical experiences and existing literature. Demographic covariates included age, sex, race, poverty to income ratio (PIR), marital status, and educational level. The body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were collected in the same way as our previous reports [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Hypertension were defined as having a diagnosis of hypertension, taking antihypertensive medications, or having three consecutive SBP readings&#8201;&#8805;&#8201;140 mmHg or DBP readings&#8201;&#8805;&#8201;90 mmHg. Diabetes was defined as having a diagnosis of diabetes, taking hypoglycemic medications, glycated hemoglobin&#8201;&#8805;&#8201;6.5%, or fasting plasma glucose&#8201;&#8805;&#8201;126&#160;mg/dL. Hyperlipidemia were defined as &#8220;yes&#8221; based on currently taking prescribed medication for hyperlipidemia or having been diagnosed with hyperlipidemia by a physician. Presence of sleep disorder was defined as &#8220;yes&#8221; based on diagnosis by a doctor of trouble sleeping. Physical activity (vigorous, moderate, no) in a typical week was defined as follows: Intensity of physical activity was classified as vigorous (activity that caused participants&#8217; breathing or heart rate to increase significantly for at least 10&#160;min continuously, such as construction work, or digging, lifting, carrying heavy loads), or moderate (activity that caused participants&#8217; breathing or heart rate to increase slightly, such as carrying light loads or brisk walking for at least 10&#160;min continuously) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. The 2,5-dimethylfuran acted as a smoking biomarker with good sensitivity and specificity. The cutoff point for differentiating between current daily smokers and less than daily smokers (&lt;&#8201;1 CPD), which includes nonsmokers, was set at a blood 2,5-dimethylfuran concentration of 0.014 ng/mL [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. We used this criteria to distinguish between daily smokers an non-daily smokers. Blood biochemical indices, including triglycerides (mg/dL), cholesterol (mg/dL), glucose (mg/dL), glycohemoglobin (%), and high-density lipoproteins (mg/dL) were tested based on the NHANES laboratory procedure manual(s) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/nhanes.htm">http://www.cdc.gov/nchs/nhanes.htm</ext-link>).</p></sec><sec id="Sec6"><title>Statistical analyses</title><p id="Par11">An appropriate NHANES sample weight was used in the analysis according to the CDC guidelines and the multistage cluster survey design. Continuous data are presented as mean &#177; standard error (SE), and categorical data are presented as percentages. When analyzing the intergroup differences, weighted linear regression was utilized to analyze measurement data and weighted chi-square test was used to analyze continuous data. Univariate and multivariate logistic analyses were utilized to calculate the odds ratio (OR) and 95% confidence interval (CI) to estimate the association between selected VOCs exposure and nonfatal cardio-cerebrovascular events. Weighted multivariate logistic regression was utilized in the multivariate analysis. Covariates that were known to be traditional or suspected risk factors for cardio-cerebrovascular or the estimates of the VOCs exposure on nonfatal cardio-cerebrovascular events changed by more than 10% in the multivariate logistic regression models. Stratified subgroup analysis was performed by smoking status, and the log-likelihood ratio test was utilized to detect the heterogeneity of the association in the presence or absence of daily smoking. R version 3.6.1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.r-project">https://www.r-project</ext-link>. org/) were used for statistical analyses. A <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.01 was considered statistically significant for all analyses.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Baseline characteristics of the participants</title><p id="Par12">The detection limits for the benzene, ethylbenzene, and o-xylene concentrations and m-/p-Xylene concentration were 0.024 and 0.034 ng/mL, respectively. The detection rates of benzene, ethylbenzene, o-xylene, and m-/p-xylene were 35%, 29%, 28%, and 65%, respectively. The median benzene level was 0.017 ng/mL (IQR, 0.017&#8211;0.043 ng/mL), median ethylbenzene level was 0.017 ng/mL (IQR, 0.017&#8211;0.030 ng/mL), median o-xylene level was 0.017 ng/mL (IQR, 0.017&#8211;0.027 ng/mL), and median m-/p-xylene level was 0.046 ng/mL (IQR, 0.024&#8211;0.096 ng/mL). The baseline characteristics of the selected VOCs are presented in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. The incidence of nonfatal cardio-cerebrovascular events was high in the high-VOCs exposure group. The weighted incidences of nonfatal cardio-cerebrovascular events in high and low-VOCs exposure groups were 7.39% vs. 6.37% for benzene exposure, 8.05% vs. 6.15% for ethylbenzene exposure, 8.31% vs. 6.05% for o-xylene exposure, and 7.22% vs. 6.19% for m-/p-xylene exposure. The baseline characteristics of the weighted population are presented in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.</p><p id="Par13">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of selected blood VOCs in NHANES 2013&#8211;2018</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">VOCs</th><th align="left" colspan="1" rowspan="1">LOD(ng/mL)</th><th align="left" colspan="1" rowspan="1">Above LOD, <italic toggle="yes">n</italic></th><th align="left" colspan="1" rowspan="1">Below LOD, <italic toggle="yes">n</italic></th><th align="left" colspan="1" rowspan="1">Detect Rate(%)</th><th align="left" colspan="1" rowspan="1">Median (Q1-Q3) (ng/mL)</th><th align="left" colspan="1" rowspan="1">Low-exposure group, <italic toggle="yes">n</italic></th><th align="left" colspan="1" rowspan="1">High-exposure group, <italic toggle="yes">n</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Blood benzene</td><td char="." align="char" colspan="1" rowspan="1">0.024</td><td char="." align="char" colspan="1" rowspan="1">1380</td><td char="." align="char" colspan="1" rowspan="1">2588</td><td char="." align="char" colspan="1" rowspan="1">35</td><td char="." align="char" colspan="1" rowspan="1">0.017 (0.017&#8211;0.043)</td><td char="." align="char" colspan="1" rowspan="1">1380</td><td char="." align="char" colspan="1" rowspan="1">2588</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Ethylbenzene</td><td char="." align="char" colspan="1" rowspan="1">0.024</td><td char="." align="char" colspan="1" rowspan="1">1166</td><td char="." align="char" colspan="1" rowspan="1">2802</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="." align="char" colspan="1" rowspan="1">0.017 (0.017&#8211;0.030)</td><td char="." align="char" colspan="1" rowspan="1">1166</td><td char="." align="char" colspan="1" rowspan="1">2802</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood o-Xylene</td><td char="." align="char" colspan="1" rowspan="1">0.024</td><td char="." align="char" colspan="1" rowspan="1">1126</td><td char="." align="char" colspan="1" rowspan="1">2842</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">0.017 (0.017&#8211;0.027)</td><td char="." align="char" colspan="1" rowspan="1">1126</td><td char="." align="char" colspan="1" rowspan="1">2842</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood m-/p-Xylene</td><td char="." align="char" colspan="1" rowspan="1">0.034</td><td char="." align="char" colspan="1" rowspan="1">2594</td><td char="." align="char" colspan="1" rowspan="1">1374</td><td char="." align="char" colspan="1" rowspan="1">65</td><td char="." align="char" colspan="1" rowspan="1">0.046 (0.024&#8211;0.096)</td><td char="." align="char" colspan="1" rowspan="1">1948</td><td char="." align="char" colspan="1" rowspan="1">2020</td></tr><tr><td align="left" colspan="1" rowspan="1">BTEXs</td><td char="." align="char" colspan="1" rowspan="1">0.106</td><td char="." align="char" colspan="1" rowspan="1">1908</td><td char="." align="char" colspan="1" rowspan="1">2060</td><td char="." align="char" colspan="1" rowspan="1">48</td><td char="." align="char" colspan="1" rowspan="1">0.103 (0.075&#8211;0.204)</td><td char="." align="char" colspan="1" rowspan="1">1908</td><td char="." align="char" colspan="1" rowspan="1">2060</td></tr></tbody></table><table-wrap-foot><p>VOCs, benzene, toluene, ethylbenzene and xylenes; LOD, Limit of detection, value below the LOD substituted as LOD/<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \sqrt{2}$$\end{document}</tex-math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12889_2024_18115_Article_IEq1.gif"/></alternatives></inline-formula></p><p>VOCs exposure classified into high and low exposure group based on their low limit detect concentration or median value</p><p>BTEXs was the sum of benzene, Ethylbenzene, o-Xylene, and m-/p-Xylene</p></table-wrap-foot></table-wrap>
</p><p id="Par14">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Baseline characteristics of study participants in NHANES 2013&#8211;2018, weighted</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="2" rowspan="1">Blood Benzene</th><th align="left" colspan="2" rowspan="1">Blood Ethylbenzene</th><th align="left" colspan="2" rowspan="1">Blood o-Xylene</th><th align="left" colspan="2" rowspan="1">Blood m-/p-Xylene</th></tr><tr><th align="left" colspan="1" rowspan="1">Low-exposure</th><th align="left" colspan="1" rowspan="1">High-exposure</th><th align="left" colspan="1" rowspan="1">Low-exposure</th><th align="left" colspan="1" rowspan="1">High-exposure</th><th align="left" colspan="1" rowspan="1">Low-exposure</th><th align="left" colspan="1" rowspan="1">High-exposure</th><th align="left" colspan="1" rowspan="1">Low-exposure</th><th align="left" colspan="1" rowspan="1">High-exposure</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Total (unweighted)</td><td align="left" colspan="1" rowspan="1">2588</td><td align="left" colspan="1" rowspan="1">1380</td><td align="left" colspan="1" rowspan="1">2802</td><td align="left" colspan="1" rowspan="1">1166</td><td align="left" colspan="1" rowspan="1">2842</td><td align="left" colspan="1" rowspan="1">1126</td><td align="left" colspan="1" rowspan="1">1948</td><td align="left" colspan="1" rowspan="1">2020</td></tr><tr><td align="left" colspan="1" rowspan="1">Total (weighted, US population estimate)</td><td align="left" colspan="1" rowspan="1">106,800,394</td><td align="left" colspan="1" rowspan="1">54,660,310</td><td align="left" colspan="1" rowspan="1">113,135,001</td><td align="left" colspan="1" rowspan="1">48,325,704</td><td align="left" colspan="1" rowspan="1">113,588,897</td><td align="left" colspan="1" rowspan="1">47,871,807</td><td align="left" colspan="1" rowspan="1">78,540,683</td><td align="left" colspan="1" rowspan="1">82,920,022</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">49.23&#177;0.58</td><td align="left" colspan="1" rowspan="1">45.46&#177;0.65</td><td align="left" colspan="1" rowspan="1">48.47&#177;0.54</td><td align="left" colspan="1" rowspan="1">46.75&#177;0.77</td><td align="left" colspan="1" rowspan="1">47.95&#177;0.55</td><td align="left" colspan="1" rowspan="1">47.98&#177;0.77</td><td align="left" colspan="1" rowspan="1">48.62&#177;0.69</td><td align="left" colspan="1" rowspan="1">47.32&#177;0.61</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">46.71</td><td align="left" colspan="1" rowspan="1">52.13</td><td align="left" colspan="1" rowspan="1">45.60</td><td align="left" colspan="1" rowspan="1">55.45</td><td align="left" colspan="1" rowspan="1">45.83</td><td align="left" colspan="1" rowspan="1">54.98</td><td align="left" colspan="1" rowspan="1">43.01</td><td align="left" colspan="1" rowspan="1">53.79</td></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">53.29</td><td align="left" colspan="1" rowspan="1">47.87</td><td align="left" colspan="1" rowspan="1">54.40</td><td align="left" colspan="1" rowspan="1">44.55</td><td align="left" colspan="1" rowspan="1">54.17</td><td align="left" colspan="1" rowspan="1">45.02</td><td align="left" colspan="1" rowspan="1">56.99</td><td align="left" colspan="1" rowspan="1">46.21</td></tr><tr><td align="left" colspan="1" rowspan="1">Race, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mexican American</td><td align="left" colspan="1" rowspan="1">8.86</td><td align="left" colspan="1" rowspan="1">8.72</td><td align="left" colspan="1" rowspan="1">10.14</td><td align="left" colspan="1" rowspan="1">5.70</td><td align="left" colspan="1" rowspan="1">10.38</td><td align="left" colspan="1" rowspan="1">5.09</td><td align="left" colspan="1" rowspan="1">9.41</td><td align="left" colspan="1" rowspan="1">8.25</td></tr><tr><td align="left" colspan="1" rowspan="1">Other races</td><td align="left" colspan="1" rowspan="1">17.31</td><td align="left" colspan="1" rowspan="1">14.32</td><td align="left" colspan="1" rowspan="1">17.15</td><td align="left" colspan="1" rowspan="1">14.31</td><td align="left" colspan="1" rowspan="1">17.39</td><td align="left" colspan="1" rowspan="1">13.71</td><td align="left" colspan="1" rowspan="1">17.31</td><td align="left" colspan="1" rowspan="1">15.34</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-hispanic White</td><td align="left" colspan="1" rowspan="1">63.55</td><td align="left" colspan="1" rowspan="1">63.17</td><td align="left" colspan="1" rowspan="1">62.36</td><td align="left" colspan="1" rowspan="1">65.91</td><td align="left" colspan="1" rowspan="1">61.36</td><td align="left" colspan="1" rowspan="1">68.32</td><td align="left" colspan="1" rowspan="1">62.37</td><td align="left" colspan="1" rowspan="1">64.42</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-hispanic Black</td><td align="left" colspan="1" rowspan="1">10.28</td><td align="left" colspan="1" rowspan="1">13.79</td><td align="left" colspan="1" rowspan="1">10.35</td><td align="left" colspan="1" rowspan="1">14.08</td><td align="left" colspan="1" rowspan="1">10.87</td><td align="left" colspan="1" rowspan="1">12.88</td><td align="left" colspan="1" rowspan="1">10.91</td><td align="left" colspan="1" rowspan="1">11.99</td></tr><tr><td align="left" colspan="1" rowspan="1">Educational level, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;High school</td><td align="left" colspan="1" rowspan="1">11.00</td><td align="left" colspan="1" rowspan="1">17.77</td><td align="left" colspan="1" rowspan="1">11.15</td><td align="left" colspan="1" rowspan="1">18.32</td><td align="left" colspan="1" rowspan="1">11.69</td><td align="left" colspan="1" rowspan="1">17.10</td><td align="left" colspan="1" rowspan="1">10.99</td><td align="left" colspan="1" rowspan="1">15.48</td></tr><tr><td align="left" colspan="1" rowspan="1">High school</td><td align="left" colspan="1" rowspan="1">20.63</td><td align="left" colspan="1" rowspan="1">28.59</td><td align="left" colspan="1" rowspan="1">20.27</td><td align="left" colspan="1" rowspan="1">30.49</td><td align="left" colspan="1" rowspan="1">20.51</td><td align="left" colspan="1" rowspan="1">30.00</td><td align="left" colspan="1" rowspan="1">20.30</td><td align="left" colspan="1" rowspan="1">26.20</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;High school</td><td align="left" colspan="1" rowspan="1">68.36</td><td align="left" colspan="1" rowspan="1">53.63</td><td align="left" colspan="1" rowspan="1">68.58</td><td align="left" colspan="1" rowspan="1">51.19</td><td align="left" colspan="1" rowspan="1">67.79</td><td align="left" colspan="1" rowspan="1">52.89</td><td align="left" colspan="1" rowspan="1">68.71</td><td align="left" colspan="1" rowspan="1">58.32</td></tr><tr><td align="left" colspan="1" rowspan="1">Marital status, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Married/living with partner</td><td align="left" colspan="1" rowspan="1">66.13</td><td align="left" colspan="1" rowspan="1">57.75</td><td align="left" colspan="1" rowspan="1">64.34</td><td align="left" colspan="1" rowspan="1">60.84</td><td align="left" colspan="1" rowspan="1">63.81</td><td align="left" colspan="1" rowspan="1">62.06</td><td align="left" colspan="1" rowspan="1">63.58</td><td align="left" colspan="1" rowspan="1">63.02</td></tr><tr><td align="left" colspan="1" rowspan="1">Widowed/divorced/separated</td><td align="left" colspan="1" rowspan="1">16.80</td><td align="left" colspan="1" rowspan="1">20.85</td><td align="left" colspan="1" rowspan="1">17.32</td><td align="left" colspan="1" rowspan="1">20.16</td><td align="left" colspan="1" rowspan="1">17.52</td><td align="left" colspan="1" rowspan="1">19.70</td><td align="left" colspan="1" rowspan="1">17.52</td><td align="left" colspan="1" rowspan="1">18.78</td></tr><tr><td align="left" colspan="1" rowspan="1">Never married</td><td align="left" colspan="1" rowspan="1">17.07</td><td align="left" colspan="1" rowspan="1">21.41</td><td align="left" colspan="1" rowspan="1">18.34</td><td align="left" colspan="1" rowspan="1">19.01</td><td align="left" colspan="1" rowspan="1">18.67</td><td align="left" colspan="1" rowspan="1">18.24</td><td align="left" colspan="1" rowspan="1">18.89</td><td align="left" colspan="1" rowspan="1">18.20</td></tr><tr><td align="left" colspan="1" rowspan="1">PIR, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;1.2</td><td align="left" colspan="1" rowspan="1">16.47</td><td align="left" colspan="1" rowspan="1">26.35</td><td align="left" colspan="1" rowspan="1">17.25</td><td align="left" colspan="1" rowspan="1">25.82</td><td align="left" colspan="1" rowspan="1">18.51</td><td align="left" colspan="1" rowspan="1">22.90</td><td align="left" colspan="1" rowspan="1">17.73</td><td align="left" colspan="1" rowspan="1">21.79</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;1.2</td><td align="left" colspan="1" rowspan="1">83.53</td><td align="left" colspan="1" rowspan="1">73.65</td><td align="left" colspan="1" rowspan="1">82.75</td><td align="left" colspan="1" rowspan="1">74.18</td><td align="left" colspan="1" rowspan="1">81.49</td><td align="left" colspan="1" rowspan="1">77.10</td><td align="left" colspan="1" rowspan="1">82.27</td><td align="left" colspan="1" rowspan="1">78.21</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;25&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">24.10</td><td align="left" colspan="1" rowspan="1">29.50</td><td align="left" colspan="1" rowspan="1">25.28</td><td align="left" colspan="1" rowspan="1">27.45</td><td align="left" colspan="1" rowspan="1">25.24</td><td align="left" colspan="1" rowspan="1">27.56</td><td align="left" colspan="1" rowspan="1">25.51</td><td align="left" colspan="1" rowspan="1">26.33</td></tr><tr><td align="left" colspan="1" rowspan="1">25&#8211;30&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">33.67</td><td align="left" colspan="1" rowspan="1">31.84</td><td align="left" colspan="1" rowspan="1">31.99</td><td align="left" colspan="1" rowspan="1">35.54</td><td align="left" colspan="1" rowspan="1">32.25</td><td align="left" colspan="1" rowspan="1">34.96</td><td align="left" colspan="1" rowspan="1">31.48</td><td align="left" colspan="1" rowspan="1">34.54</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;30&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">42.22</td><td align="left" colspan="1" rowspan="1">38.66</td><td align="left" colspan="1" rowspan="1">42.73</td><td align="left" colspan="1" rowspan="1">37.00</td><td align="left" colspan="1" rowspan="1">42.51</td><td align="left" colspan="1" rowspan="1">37.48</td><td align="left" colspan="1" rowspan="1">43.01</td><td align="left" colspan="1" rowspan="1">39.13</td></tr><tr><td align="left" colspan="1" rowspan="1">Cholesterol (mg/dl)</td><td align="left" colspan="1" rowspan="1">190.86&#177;1.36</td><td align="left" colspan="1" rowspan="1">191.50&#177;1.83</td><td align="left" colspan="1" rowspan="1">190.89&#177;1.26</td><td align="left" colspan="1" rowspan="1">191.51&#177;1.76</td><td align="left" colspan="1" rowspan="1">190.31&#177;1.26</td><td align="left" colspan="1" rowspan="1">192.89&#177;1.87</td><td align="left" colspan="1" rowspan="1">189.22&#177;1.58</td><td align="left" colspan="1" rowspan="1">192.83&#177;1.27</td></tr><tr><td align="left" colspan="1" rowspan="1">Triglycerides (mg/dl)</td><td align="left" colspan="1" rowspan="1">148.24&#177;3.69</td><td align="left" colspan="1" rowspan="1">152.37&#177;4.82</td><td align="left" colspan="1" rowspan="1">149.32&#177;3.85</td><td align="left" colspan="1" rowspan="1">150.40&#177;4.09</td><td align="left" colspan="1" rowspan="1">149.03&#177;3.81</td><td align="left" colspan="1" rowspan="1">151.08&#177;4.84</td><td align="left" colspan="1" rowspan="1">146.46&#177;4.59</td><td align="left" colspan="1" rowspan="1">152.65&#177;3.68</td></tr><tr><td align="left" colspan="1" rowspan="1">HDL (mg/dl)</td><td align="left" colspan="1" rowspan="1">54.66&#177;0.55</td><td align="left" colspan="1" rowspan="1">53.09&#177;0.71</td><td align="left" colspan="1" rowspan="1">54.68&#177;0.63</td><td align="left" colspan="1" rowspan="1">52.83&#177;0.66</td><td align="left" colspan="1" rowspan="1">54.41&#177;0.61</td><td align="left" colspan="1" rowspan="1">53.46&#177;0.70</td><td align="left" colspan="1" rowspan="1">54.88&#177;0.77</td><td align="left" colspan="1" rowspan="1">53.41&#177;0.53</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum cotinine (ng/mL)</td><td align="left" colspan="1" rowspan="1">10.93&#177;1.82</td><td align="left" colspan="1" rowspan="1">133.20&#177;8.58</td><td align="left" colspan="1" rowspan="1">14.73&#177;2.35</td><td align="left" colspan="1" rowspan="1">140.33&#177;9.56</td><td align="left" colspan="1" rowspan="1">20.19&#177;2.41</td><td align="left" colspan="1" rowspan="1">128.58&#177;9.85</td><td align="left" colspan="1" rowspan="1">12.27&#177;2.25</td><td align="left" colspan="1" rowspan="1">90.27&#177;5.67</td></tr><tr><td align="left" colspan="1" rowspan="1">Physicial activity, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Vigorous</td><td align="left" colspan="1" rowspan="1">19.86</td><td align="left" colspan="1" rowspan="1">31.08</td><td align="left" colspan="1" rowspan="1">19.34</td><td align="left" colspan="1" rowspan="1">33.77</td><td align="left" colspan="1" rowspan="1">20.16</td><td align="left" colspan="1" rowspan="1">31.96</td><td align="left" colspan="1" rowspan="1">18.59</td><td align="left" colspan="1" rowspan="1">28.46</td></tr><tr><td align="left" colspan="1" rowspan="1">Moderate</td><td align="left" colspan="1" rowspan="1">25.73</td><td align="left" colspan="1" rowspan="1">22.88</td><td align="left" colspan="1" rowspan="1">25.66</td><td align="left" colspan="1" rowspan="1">22.67</td><td align="left" colspan="1" rowspan="1">25.87</td><td align="left" colspan="1" rowspan="1">22.14</td><td align="left" colspan="1" rowspan="1">26.26</td><td align="left" colspan="1" rowspan="1">23.34</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">54.41</td><td align="left" colspan="1" rowspan="1">46.04</td><td align="left" colspan="1" rowspan="1">55.00</td><td align="left" colspan="1" rowspan="1">43.56</td><td align="left" colspan="1" rowspan="1">53.97</td><td align="left" colspan="1" rowspan="1">45.90</td><td align="left" colspan="1" rowspan="1">55.14</td><td align="left" colspan="1" rowspan="1">48.20</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">17.15</td><td align="left" colspan="1" rowspan="1">12.72</td><td align="left" colspan="1" rowspan="1">16.91</td><td align="left" colspan="1" rowspan="1">12.70</td><td align="left" colspan="1" rowspan="1">16.44</td><td align="left" colspan="1" rowspan="1">13.78</td><td align="left" colspan="1" rowspan="1">17.23</td><td align="left" colspan="1" rowspan="1">14.15</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">82.85</td><td align="left" colspan="1" rowspan="1">87.28</td><td align="left" colspan="1" rowspan="1">83.09</td><td align="left" colspan="1" rowspan="1">87.30</td><td align="left" colspan="1" rowspan="1">83.56</td><td align="left" colspan="1" rowspan="1">86.22</td><td align="left" colspan="1" rowspan="1">82.77</td><td align="left" colspan="1" rowspan="1">85.85</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">41.07</td><td align="left" colspan="1" rowspan="1">38.14</td><td align="left" colspan="1" rowspan="1">39.73</td><td align="left" colspan="1" rowspan="1">40.91</td><td align="left" colspan="1" rowspan="1">39.42</td><td align="left" colspan="1" rowspan="1">41.65</td><td align="left" colspan="1" rowspan="1">39.43</td><td align="left" colspan="1" rowspan="1">40.70</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">58.93</td><td align="left" colspan="1" rowspan="1">61.86</td><td align="left" colspan="1" rowspan="1">60.27</td><td align="left" colspan="1" rowspan="1">59.09</td><td align="left" colspan="1" rowspan="1">60.58</td><td align="left" colspan="1" rowspan="1">58.35</td><td align="left" colspan="1" rowspan="1">60.57</td><td align="left" colspan="1" rowspan="1">59.30</td></tr><tr><td align="left" colspan="1" rowspan="1">Hyperlipidemia, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">38.39</td><td align="left" colspan="1" rowspan="1">30.43</td><td align="left" colspan="1" rowspan="1">36.69</td><td align="left" colspan="1" rowspan="1">33.36</td><td align="left" colspan="1" rowspan="1">36.42</td><td align="left" colspan="1" rowspan="1">33.97</td><td align="left" colspan="1" rowspan="1">36.47</td><td align="left" colspan="1" rowspan="1">34.97</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">61.61</td><td align="left" colspan="1" rowspan="1">69.57</td><td align="left" colspan="1" rowspan="1">63.31</td><td align="left" colspan="1" rowspan="1">66.64</td><td align="left" colspan="1" rowspan="1">63.58</td><td align="left" colspan="1" rowspan="1">66.03</td><td align="left" colspan="1" rowspan="1">63.53</td><td align="left" colspan="1" rowspan="1">65.03</td></tr><tr><td align="left" colspan="1" rowspan="1">Nonfatal cardiovascular event, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">6.37</td><td align="left" colspan="1" rowspan="1">7.39</td><td align="left" colspan="1" rowspan="1">6.15</td><td align="left" colspan="1" rowspan="1">8.05</td><td align="left" colspan="1" rowspan="1">6.05</td><td align="left" colspan="1" rowspan="1">8.31</td><td align="left" colspan="1" rowspan="1">6.19</td><td align="left" colspan="1" rowspan="1">7.22</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">93.63</td><td align="left" colspan="1" rowspan="1">92.61</td><td align="left" colspan="1" rowspan="1">93.85</td><td align="left" colspan="1" rowspan="1">91.95</td><td align="left" colspan="1" rowspan="1">93.95</td><td align="left" colspan="1" rowspan="1">91.69</td><td align="left" colspan="1" rowspan="1">93.81</td><td align="left" colspan="1" rowspan="1">92.78</td></tr></tbody></table><table-wrap-foot><p>Mean&#8201;&#177;&#8201;standard error (SE) for continuous data. Percentage (%) for categorical data</p><p>PIR, poverty to income ratio; BMI, body mass index; HDL, high density lipoprotein</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec9"><title>High VOCs exposure was associated with higher incidence of nonfatal cardio-cerebrovascular events</title><p id="Par15">Weighted univariate logistic regression analysis revealed that the ORs with 95% CI of nonfatal cardio-cerebrovascular events for high exposure to the selected VOCs, benzene, ethylbenzene, o-xylene, m-/p-xylene, and their sum BTEXs were 1.17 (0.87, 1.58), 1.34 (1.00, 1.78), 1.41 (1.08, 1.84), 1.18 (0.86, 1.61), and 1.21 (0.88, 1.66), respectively, compared with those for the low exposure to these selected VOCs, as shown in Table&#160;<xref rid="Tab3" ref-type="table">3</xref>.</p><p id="Par16">High VOCs exposure was found to be positively associated with nonfatal cardiovascular events in the weighted multivariate logistic regression analysis, and the adjusted ORs and 95% CIs of nonfatal cardio-cerebrovascular events for high exposure to benzene, ethylbenzene, o-xylene,m-/p-xylene, and their sum BTEXs were 1.41 (0.91, 2.19), 1.37 (0.96, 1.95), 1.32 (0.96, 1.82), and 1.17 (0.82, 1.67), and 1.26(0.84, 1.89) respectively, after adjustment for age, sex, race, marital status, educational level, BMI, serum cotinine, hyperlipidemia, hypertension, and diabetes, as shown in Table&#160;<xref rid="Tab4" ref-type="table">4</xref>. When imputed blood VOCs concentrations below LOD with 0 and the LOD value, we also found that high VOCs exposure tended to be positively associated with nonfatal cardiovascular events, as shown in Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>-<xref rid="MOESM1" ref-type="media">S4</xref>. These results indicate that there was a positive association between selected VOCs exposure and nonfatal cardio-cerebrovascular events.</p><p id="Par17">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Results of the univariate logistic regression analysis, weighted</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Statistic</th><th align="left" colspan="1" rowspan="1">OR (95%CI) <italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">47.95&#177;0.46</td><td align="left" colspan="1" rowspan="1">1.07 (1.06, 1.08)&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">48.55</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">51.45</td><td align="left" colspan="1" rowspan="1">0.83 (0.61, 1.12) 0.2351</td></tr><tr><td align="left" colspan="1" rowspan="1">Race, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mexican American</td><td align="left" colspan="1" rowspan="1">8.81</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Other races</td><td align="left" colspan="1" rowspan="1">16.30</td><td align="left" colspan="1" rowspan="1">0.72 (0.39, 1.34) 0.3048</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-hispanic White</td><td align="left" colspan="1" rowspan="1">63.42</td><td align="left" colspan="1" rowspan="1">1.56 (1.04, 2.35) 0.0371</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-hispanic Black</td><td align="left" colspan="1" rowspan="1">11.47</td><td align="left" colspan="1" rowspan="1">1.48 (0.99, 2.21) 0.0641</td></tr><tr><td align="left" colspan="1" rowspan="1">Educational level, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;High school</td><td align="left" colspan="1" rowspan="1">13.30</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High school</td><td align="left" colspan="1" rowspan="1">23.33</td><td align="left" colspan="1" rowspan="1">0.86 (0.55, 1.34) 0.5144</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;High school</td><td align="left" colspan="1" rowspan="1">63.37</td><td align="left" colspan="1" rowspan="1">0.56 (0.38, 0.83) 0.0059</td></tr><tr><td align="left" colspan="1" rowspan="1">Marital status, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Married/living with partner</td><td align="left" colspan="1" rowspan="1">63.29</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Widowed/divorced/separated</td><td align="left" colspan="1" rowspan="1">18.17</td><td align="left" colspan="1" rowspan="1">1.80 (1.33, 2.45) 0.0005</td></tr><tr><td align="left" colspan="1" rowspan="1">Never married</td><td align="left" colspan="1" rowspan="1">18.54</td><td align="left" colspan="1" rowspan="1">0.41 (0.25, 0.66) 0.0007</td></tr><tr><td align="left" colspan="1" rowspan="1">PIR, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;1.2</td><td align="left" colspan="1" rowspan="1">19.82</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;1.2</td><td align="left" colspan="1" rowspan="1">80.18</td><td align="left" colspan="1" rowspan="1">0.79 (0.58, 1.07) 0.1296</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;25&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">25.93</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">25&#8211;30&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">33.05</td><td align="left" colspan="1" rowspan="1">1.36 (0.90, 2.05) 0.1468</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;30&#160;kg/m<sup>2</sup></td><td align="left" colspan="1" rowspan="1">41.02</td><td align="left" colspan="1" rowspan="1">1.72 (1.11, 2.66) 0.0187</td></tr><tr><td align="left" colspan="1" rowspan="1">Cholesterol (mg/dl)</td><td align="left" colspan="1" rowspan="1">191.08&#177;1.20</td><td align="left" colspan="1" rowspan="1">0.99 (0.99, 1.00) 0.0151</td></tr><tr><td align="left" colspan="1" rowspan="1">Triglycerides (mg/dl)</td><td align="left" colspan="1" rowspan="1">149.64&#177;3.21</td><td align="left" colspan="1" rowspan="1">1.00 (1.00, 1.00) 0.1423</td></tr><tr><td align="left" colspan="1" rowspan="1">HDL (mg/dl)</td><td align="left" colspan="1" rowspan="1">54.13&#177;0.46</td><td align="left" colspan="1" rowspan="1">0.99 (0.97, 1.00) 0.1181</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum cotinine (ng/mL)</td><td align="left" colspan="1" rowspan="1">52.34&#177;2.69</td><td align="left" colspan="1" rowspan="1">1.03 (1.00, 1.06) 0.0396</td></tr><tr><td align="left" colspan="1" rowspan="1">Physicial activity, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">51.58</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Moderate</td><td align="left" colspan="1" rowspan="1">24.76</td><td align="left" colspan="1" rowspan="1">0.99 (0.69, 1.43) 0.9755</td></tr><tr><td align="left" colspan="1" rowspan="1">Vigorous</td><td align="left" colspan="1" rowspan="1">23.66</td><td align="left" colspan="1" rowspan="1">0.80 (0.53, 1.22) 0.3108</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">84.35</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">15.65</td><td align="left" colspan="1" rowspan="1">4.48 (3.10, 6.47)&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">59.92</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">40.08</td><td align="left" colspan="1" rowspan="1">3.69 (2.48, 5.49)&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hyperlipidemia, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">64.30</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">35.70</td><td align="left" colspan="1" rowspan="1">5.14 (3.76, 7.03)&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood benzene, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">66.15</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">33.85</td><td align="left" colspan="1" rowspan="1">1.17 (0.87, 1.58) 0.2968</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Ethylbenzene, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">70.07</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">29.93</td><td align="left" colspan="1" rowspan="1">1.34 (1.00, 1.78) 0.0549</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood o-Xylene, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">70.35</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">29.65</td><td align="left" colspan="1" rowspan="1">1.41 (1.08, 1.84) 0.0159</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood m-/p-Xylene, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">48.64</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">51.36</td><td align="left" colspan="1" rowspan="1">1.18 (0.86, 1.61) 0.3076</td></tr><tr><td align="left" colspan="1" rowspan="1">BTEXs, <italic toggle="yes">n</italic> (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">51.83</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">48.17</td><td align="left" colspan="1" rowspan="1">1.21 (0.88, 1.66) 0.2464</td></tr></tbody></table><table-wrap-foot><p>BTEXs was the sum of benzene, Ethylbenzene, o-Xylene, and m-/p-Xylene</p><p>PIR, poverty to income ratio; BMI, body mass index; HDL, high density lipoprotein; OR, odds ration; 95% CI, 95% confidence interval</p></table-wrap-foot></table-wrap>
</p><p id="Par18">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Results of the multivariate logistic regression analysis, weighted</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">OR (95% CI) <italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Blood benzene</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.41(0.91, 2.19) 0.1370</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Ethylbenzene</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.37 (0.96, 1.95) 0.0924</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood o-Xylene</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.32 (0.96, 1.82) 0.0936</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood m-/p-Xylene</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.17 (0.82, 1.67) 0.3843</td></tr><tr><td align="left" colspan="1" rowspan="1">BTEXs</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.26 (0.84, 1.89) 0.2651</td></tr></tbody></table><table-wrap-foot><p>Adjusted for age, sex, race, marital status, educational level, BMI, serum cotinine, hyperlipidemia, hypertension, and diabetes</p><p>BTEXs was the sum of benzene, Ethylbenzene, o-Xylene, and m-/p-Xylene</p><p>OR, odds ration; 95% CI, 95% confidence interval</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Subgroup analysis</title><p id="Par19">We further conducted a subgroup analysis to determine the robustness and consistency of the association between selected VOCs exposure and nonfatal cardio-cerebrovascular events in the daily smokers an non-daily smokers when adjusted for age, sex, race, marital status, educational level, BMI, hyperlipidemia, hypertension, and diabetes. The association between selected VOCs exposure and non-fatal cardio-cerebrovascular events was not dependent on smoking status (all <italic toggle="yes">p-</italic>interaction&#8201;&gt;&#8201;0.01). High VOCs exposure was associated with an increased risk of nonfatal cardio-cerebrovascular events in both daily smokers an non-daily smokers, but the association was not statistically significant in non-daily smokers, as shown in Table&#160;<xref rid="Tab5" ref-type="table">5</xref>.</p><p id="Par20">
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Results of subgroup analysis bases on smoke status</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">OR (95%CI) <italic toggle="yes">P</italic>-value</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>-interaction</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Smoke status (Yes)</td><td align="left" colspan="1" rowspan="1">Smoke status (No)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Blood Benzene</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.3015</td></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.81 (1.10, 3.00) 0.0273</td><td align="left" colspan="1" rowspan="1">1.20 (0.65, 2.22) 0.5646</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Blood Ethylbenzene</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.3236</td></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.84 (1.29, 2.63) 0.0020</td><td align="left" colspan="1" rowspan="1">1.13 (0.49, 2.62) 0.7774</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Blood o-Xylene</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.3744</td></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.67 (1.17, 2.38) 0.0088</td><td align="left" colspan="1" rowspan="1">1.21 (0.67, 2.18) 0.5369</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Blood m-/p-Xylene</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.2723</td></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.50 (0.99, 2.26) 0.0645</td><td align="left" colspan="1" rowspan="1">1.10 (0.71, 1.72) 0.6637</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">BTEXs</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.2341</td></tr><tr><td align="left" colspan="1" rowspan="1">Low-exposure group</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1">Ref.</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High-exposure group</td><td align="left" colspan="1" rowspan="1">1.62 (1.06, 2.48) 0.0340</td><td align="left" colspan="1" rowspan="1">1.18 (0.72, 1.93) 0.5125</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Adjusted for age, sex, race, marital status, educational level, BMI, hyperlipidemia, hypertension, and diabetes</p><p>BTEXs was the sum of benzene, Ethylbenzene, o-Xylene, and m-/p-Xylene</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par21">In the present study, we observed that high VOCs exposure was positively associated with nonfatal cardio-cerebrovascular events among adults in the US. In the subgroup analysis stratified with smoke status, we found the positive association between VOCs exposure and nonfatal cardio-cerebrovascular events was stable and robust.</p><p id="Par22">Pollution caused by VOCs has been revealed to be correlated with oxidative stress, autonomic dysfunction, systemic inflammation, and blood coagulation, which are well-established risk factors for cardiovascular diseases [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In animal models, mice exposed to volatile benzene exhibited a higher risk of developing cardiovascular diseases than those that breathed filtered air [<xref ref-type="bibr" rid="CR26">26</xref>]. Benzene was found to be negatively correlated with many types of circulating angiogenic cells (CD45<sup>dim</sup>/CD146<sup>+</sup>/CD34<sup>+</sup> cells) in human samples [<xref ref-type="bibr" rid="CR11">11</xref>]. Abplanalp et al. found that mice inhalation of volatile benzene exhibited increasing plasma levels of low-density lipoproteins and decreasing plasma levels of circulating angiogenic cells (Flk-1+/Sca-1+) [<xref ref-type="bibr" rid="CR26">26</xref>]. In other experiments, researchers also found that platelet macroparticles, percentage of CD4<sup>+</sup> and CD8<sup>+</sup> T-cells, and platelet-leukocyte aggregates were noticeably increased in mice that inhaled benzene [<xref ref-type="bibr" rid="CR27">27</xref>]. Moreover, benzene exposure can aggravate heart failure by promoting neutrophil recruitment and endothelial activation [<xref ref-type="bibr" rid="CR8">8</xref>]. Thus, VOCs exposure may aggravate cardio-cerebrovascular events by impairing the vascular endothelial function [<xref ref-type="bibr" rid="CR28">28</xref>], and reduction in air VOCs concentrations was correlated with subsequent improvements in cardiovascular health [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Meanwhile, exposure to VOCs also influenced other risk factors for cardio-cerebrovascular disease. Lee et al. revealed that benzene metabolites were associated with an increased risk of diabetes mellitus by utilizing data from the Korea National Environmental Health Survey [<xref ref-type="bibr" rid="CR31">31</xref>]. VOCs exposure also found to be associated with metabolic syndrome [<xref ref-type="bibr" rid="CR32">32</xref>]. However, the mechanisms responsible for thses association needs to be further investigated.</p><p id="Par23">For the general public, the most significant source of exposure to VOCs is smoking. Consistent with this, this study found higher smoking rate was found in the high VOCs exposure group. In the subgroup analysis by presence or absence of daily smoking, We found that the positive association was was stable and robust in both daily smokers an non-daily smokers. The study of genetic risk factors for cerebrovascular disease revealed that single nucleotide polymorphisms (SNPs)-chromosome 8 loci with potential roles in vascular endothelial maintenance was independent of smoking [<xref ref-type="bibr" rid="CR33">33</xref>]. The association between rs1333040 SNP and cerebrovascular disease was also found to be independent of smoking [<xref ref-type="bibr" rid="CR34">34</xref>]. We hypothesized that smoking exposure may not alter genetic sensitivity to BTEXs and that exposure to BTEXs increased the risk of cardio-cerebrovascular disease to the similar extent in both smoking and nonsmoking participants. The positive association between high VOCs exposure and nonfatal cardiovascular or cerebrovascular events was stable and robust.</p></sec><sec id="Sec12"><title>Conclusion</title><p id="Par24">VOCs exposure is a serious environmental pollution issue, there is increasing attention to VOCs toxic effect in human health. In this study, we observed positive association between benzene, ethylbenzene, o-xylene, m-/p-xylene and nonfatal cardio-cerebrovascular events, and the positive association was stable and robust in both daily smokers an non-daily smokers, but the association was not statistically significant in non-daily smokers. In the future, programs that engage in &#8220;source emissions environmental concentration-exposure human biological monitoring- health effects surveillance&#8221; are valuable and worth exploring for VOCs. Meanwhile, further research should investigate and identify the mechanistic hypothesis to explain the cardio-cerebrovascular hazard from VOCs exposure.</p><p id="Par25">Our study also has several limitations. First, the cross-sectional design allowed us to conclude an association but not a causal inference. Second, unmeasured confounders may be a concern in our study. Although we controlled for a large number of confounding variables, the confounders, such as the use of other forms of smoked tobacco, second-hand smoke, marijuana were not included in this study, the association of BTEXs exposure and nonfatal cardio-cerebrovascular events may not be isolated fully accutate. Finally, VOCs are volatile and their levels in the blood may represent only recent exposure levels but not long-term exposure levels.</p></sec><sec sec-type="supplementary-material"><sec id="Sec13"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12889_2024_18115_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Li Jing and Tiancong Chen contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We are grateful to the NHANES database for providing access to the data.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Study conception and design: WD. Acquisition of data: WD. Analysis and interpretation of data: WD, LJ, and TC. Drafting of the manuscript:LJ and ZY. Critical revision of the manuscript for important intellectual content:WD and TC. Administrative, technical, and material support: WD, LJ, ZY, and TC. LJ and TC contributed equally to this work. All authors approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study received no external funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All dataset used in this study was taken from NHANES publicly available dataset (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/Default.aspx">https://wwwn.cdc.gov/nchs/nhanes/Default.aspx</ext-link>). The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par26">The National Center for Health Statistics and Research Ethics Review Committee approved the use of human subjects for the NHANES study and written informed consent was provided by each participant. An individual investigator utilizing the publicly available NHANES data do not need to file the institution internal review board.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par27">NA.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interest</title><p id="Par28">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mozaffarian</surname><given-names>D</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Go</surname><given-names>AS</given-names></name><name name-style="western"><surname>Arnett</surname><given-names>DK</given-names></name><name name-style="western"><surname>Blaha</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cushman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Heart disease and stroke statistics&#8211;2015 update: a report from the American Heart Association</article-title><source>Circulation</source><year>2015</year><volume>131</volume><issue>4</issue><fpage>e29</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">25520374</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000152</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Muntner</surname><given-names>P</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Bittencourt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Callaway</surname><given-names>CW</given-names></name><name name-style="western"><surname>Carson</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Heart Disease and Stroke Statistics-2019 update: a Report from the American Heart Association</article-title><source>Circulation</source><year>2019</year><volume>139</volume><issue>10</issue><fpage>e56</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000659</pub-id><pub-id pub-id-type="pmid">30700139</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Virani</surname><given-names>SS</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Bittencourt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Callaway</surname><given-names>CW</given-names></name><name name-style="western"><surname>Carson</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Heart Disease and Stroke Statistics-2020 update: a Report from the American Heart Association</article-title><source>Circulation</source><year>2020</year><volume>141</volume><issue>9</issue><fpage>e139</fpage><lpage>e596</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000757</pub-id><pub-id pub-id-type="pmid">31992061</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Climie</surname><given-names>RE</given-names></name><name name-style="western"><surname>van Sloten</surname><given-names>TT</given-names></name><name name-style="western"><surname>P&#233;rier</surname><given-names>MC</given-names></name><name name-style="western"><surname>Tafflet</surname><given-names>M</given-names></name><name name-style="western"><surname>Fayosse</surname><given-names>A</given-names></name><name name-style="western"><surname>Dugravot</surname><given-names>A</given-names></name><etal/></person-group><article-title>Change in Cardiovascular Health and Incident Type 2 diabetes and impaired fasting glucose: the Whitehall II study</article-title><source>Diabetes Care</source><year>2019</year><volume>42</volume><issue>10</issue><fpage>1981</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2337/dc19-0379</pub-id><pub-id pub-id-type="pmid">31416895</pub-id><pub-id pub-id-type="pmcid">PMC7364667</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>RY</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><name name-style="western"><surname>Ding</surname><given-names>FH</given-names></name><etal/></person-group><article-title>Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease</article-title><source>Cardiovasc Diabetol</source><year>2019</year><volume>18</volume><issue>1</issue><fpage>160</fpage><pub-id pub-id-type="doi">10.1186/s12933-019-0959-1</pub-id><pub-id pub-id-type="pmid">31733658</pub-id><pub-id pub-id-type="pmcid">PMC6858977</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>YK</given-names></name><name name-style="western"><surname>Chan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Hai</surname><given-names>JSH</given-names></name><name name-style="western"><surname>Lau</surname><given-names>KK</given-names></name><name name-style="western"><surname>Tse</surname><given-names>HF</given-names></name></person-group><article-title>Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus</article-title><source>Cardiovasc Diabetol</source><year>2021</year><volume>20</volume><issue>1</issue><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/s12933-021-01280-z</pub-id><pub-id pub-id-type="pmid">33894788</pub-id><pub-id pub-id-type="pmcid">PMC8070286</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>NC</given-names></name><name name-style="western"><surname>Dailey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Ilacqua</surname><given-names>VA</given-names></name><name name-style="western"><surname>Kearney</surname><given-names>GD</given-names></name><name name-style="western"><surname>Talbott</surname><given-names>EO</given-names></name></person-group><article-title>Association between exposure to alkylbenzenes and cardiovascular disease among National Health and Nutrition Examination Survey (NHANES) participants</article-title><source>Int J Occup Environ Health</source><year>2009</year><volume>15</volume><issue>4</issue><fpage>385</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1179/oeh.2009.15.4.385</pub-id><pub-id pub-id-type="pmid">19886349</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zelko</surname><given-names>IN</given-names></name><name name-style="western"><surname>Dassanayaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Malovichko</surname><given-names>MV</given-names></name><name name-style="western"><surname>Howard</surname><given-names>CM</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>LF</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>S</given-names></name><etal/></person-group><article-title>Chronic benzene exposure aggravates pressure overload-Induced Cardiac Dysfunction</article-title><source>Toxicol Sci</source><year>2021</year><volume>185</volume><issue>1</issue><fpage>64</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfab125</pub-id><pub-id pub-id-type="pmid">34718823</pub-id><pub-id pub-id-type="pmcid">PMC8714365</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>North</surname><given-names>CM</given-names></name><name name-style="western"><surname>Rooseboom</surname><given-names>M</given-names></name><name name-style="western"><surname>Kocabas</surname><given-names>NA</given-names></name><name name-style="western"><surname>Schnatter</surname><given-names>AR</given-names></name><name name-style="western"><surname>Faulhammer</surname><given-names>F</given-names></name><name name-style="western"><surname>Williams</surname><given-names>SD</given-names></name></person-group><article-title>Modes of action considerations in threshold expectations for health effects of benzene</article-title><source>Toxicol Lett</source><year>2020</year><volume>334</volume><fpage>78</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2020.09.005</pub-id><pub-id pub-id-type="pmid">32941992</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumgartner</surname><given-names>J</given-names></name><name name-style="western"><surname>Schauer</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Ezzati</surname><given-names>M</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Patz</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Indoor air pollution and blood pressure in adult women living in rural China</article-title><source>Environ Health Perspect</source><year>2011</year><volume>119</volume><issue>10</issue><fpage>1390</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1289/ehp.1003371</pub-id><pub-id pub-id-type="pmid">21724522</pub-id><pub-id pub-id-type="pmcid">PMC3230444</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riggs</surname><given-names>DW</given-names></name><name name-style="western"><surname>Malovichko</surname><given-names>MV</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><name name-style="western"><surname>McGraw</surname><given-names>KE</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>BS</given-names></name><name name-style="western"><surname>Krivokhizhina</surname><given-names>T</given-names></name><etal/></person-group><article-title>Environmental exposure to volatile organic compounds is associated with endothelial injury</article-title><source>Toxicol Appl Pharmacol</source><year>2022</year><volume>437</volume><fpage>115877</fpage><pub-id pub-id-type="doi">10.1016/j.taap.2022.115877</pub-id><pub-id pub-id-type="pmid">35045333</pub-id><pub-id pub-id-type="pmcid">PMC10045232</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fried</surname><given-names>ND</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>JD</given-names></name></person-group><article-title>Heat-not-burn tobacco products: an emerging threat to cardiovascular health</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2020</year><volume>319</volume><issue>6</issue><fpage>H1234</fpage><lpage>h9</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00708.2020</pub-id><pub-id pub-id-type="pmid">33006919</pub-id><pub-id pub-id-type="pmcid">PMC7792702</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>W</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name></person-group><article-title>Blood volatile organic aromatic compounds concentrations across adulthood in relation to total and cause specific mortality: a prospective cohort study</article-title><source>Chemosphere</source><year>2022</year><volume>286</volume><issue>Pt 1</issue><fpage>131590</fpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2021.131590</pub-id><pub-id pub-id-type="pmid">34293566</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>DM</given-names></name><name name-style="western"><surname>Reese</surname><given-names>CM</given-names></name><name name-style="western"><surname>Thornburg</surname><given-names>LG</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>E</given-names></name><name name-style="western"><surname>Rafson</surname><given-names>JP</given-names></name><name name-style="western"><surname>Blount</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Distinguishing Petroleum (Crude Oil and fuel) from smoke exposure within populations based on the relative blood levels of Benzene, Toluene, Ethylbenzene, and Xylenes (BTEX), Styrene and 2,5-Dimethylfuran by Pattern Recognition using Artificial neural networks</article-title><source>Environ Sci Technol</source><year>2018</year><volume>52</volume><issue>1</issue><fpage>308</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1021/acs.est.7b05128</pub-id><pub-id pub-id-type="pmid">29216422</pub-id><pub-id pub-id-type="pmcid">PMC5750095</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lueders</surname><given-names>T</given-names></name></person-group><article-title>The ecology of anaerobic degraders of BTEX hydrocarbons in aquifers</article-title><source>FEMS Microbiol Ecol</source><year>2017</year><volume>93</volume><issue>1</issue><fpage>fiw220</fpage><pub-id pub-id-type="doi">10.1093/femsec/fiw220</pub-id><pub-id pub-id-type="pmid">27810873</pub-id><pub-id pub-id-type="pmcid">PMC5400083</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolden</surname><given-names>AL</given-names></name><name name-style="western"><surname>Kwiatkowski</surname><given-names>CF</given-names></name><name name-style="western"><surname>Colborn</surname><given-names>T</given-names></name></person-group><article-title>New look at BTEX: are ambient levels a Problem?</article-title><source>Environ Sci Technol</source><year>2015</year><volume>49</volume><issue>9</issue><fpage>5261</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1021/es505316f</pub-id><pub-id pub-id-type="pmid">25873211</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>BF</given-names></name><name name-style="western"><surname>Clark</surname><given-names>ML</given-names></name><name name-style="western"><surname>Bachand</surname><given-names>A</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>TL</given-names></name><name name-style="western"><surname>Peel</surname><given-names>JL</given-names></name></person-group><article-title>Interactions between Diet and exposure to Secondhand smoke on the prevalence of childhood obesity: results from NHANES, 2007&#8211;2010</article-title><source>Environ Health Perspect</source><year>2016</year><volume>124</volume><issue>8</issue><fpage>1316</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1289/ehp.1510138</pub-id><pub-id pub-id-type="pmid">26713774</pub-id><pub-id pub-id-type="pmcid">PMC4977048</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Association of Dietary Fiber Intake with myocardial infarction and stroke events in US adults: a cross-sectional study of NHANES 2011&#8211;2018</article-title><source>Front Nutr</source><year>2022</year><volume>9</volume><fpage>936926</fpage><pub-id pub-id-type="doi">10.3389/fnut.2022.936926</pub-id><pub-id pub-id-type="pmid">35799583</pub-id><pub-id pub-id-type="pmcid">PMC9253671</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Trends in lipid profile and lipid control among survivors of stroke or myocardial infarction among US adults, 2001&#8211;2018</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1128878</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1128878</pub-id><pub-id pub-id-type="pmid">36967759</pub-id><pub-id pub-id-type="pmcid">PMC10031105</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parikh</surname><given-names>NS</given-names></name><name name-style="western"><surname>Salehi Omran</surname><given-names>S</given-names></name><name name-style="western"><surname>Kamel</surname><given-names>H</given-names></name><name name-style="western"><surname>Elkind</surname><given-names>MSV</given-names></name><name name-style="western"><surname>Willey</surname><given-names>J</given-names></name></person-group><article-title>Symptoms of depression and active smoking among survivors of stroke and myocardial infarction: an NHANES analysis</article-title><source>Prev Med</source><year>2020</year><volume>137</volume><fpage>106131</fpage><pub-id pub-id-type="doi">10.1016/j.ypmed.2020.106131</pub-id><pub-id pub-id-type="pmid">32439489</pub-id><pub-id pub-id-type="pmcid">PMC7309407</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boateng</surname><given-names>GO</given-names></name><name name-style="western"><surname>Adams</surname><given-names>EA</given-names></name><name name-style="western"><surname>Odei Boateng</surname><given-names>M</given-names></name><name name-style="western"><surname>Luginaah</surname><given-names>IN</given-names></name><name name-style="western"><surname>Taabazuing</surname><given-names>MM</given-names></name></person-group><article-title>Obesity and the burden of health risks among the elderly in Ghana: a population study</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>11</issue><fpage>e0186947</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0186947</pub-id><pub-id pub-id-type="pmid">29117264</pub-id><pub-id pub-id-type="pmcid">PMC5695605</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werder</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Gam</surname><given-names>KB</given-names></name><name name-style="western"><surname>Engel</surname><given-names>LS</given-names></name><name name-style="western"><surname>Kwok</surname><given-names>RK</given-names></name><name name-style="western"><surname>Ekenga</surname><given-names>CC</given-names></name><name name-style="western"><surname>Curry</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Predictors of blood volatile organic compound levels in Gulf coast residents</article-title><source>J Expo Sci Environ Epidemiol</source><year>2018</year><volume>28</volume><issue>4</issue><fpage>358</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/s41370-017-0010-0</pub-id><pub-id pub-id-type="pmid">29288257</pub-id><pub-id pub-id-type="pmcid">PMC6013310</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>C</given-names></name><name name-style="western"><surname>Ward</surname><given-names>KD</given-names></name><name name-style="western"><surname>Mzayek</surname><given-names>F</given-names></name><name name-style="western"><surname>Relyea</surname><given-names>G</given-names></name></person-group><article-title>Blood 2,5-dimethylfuran as a sensitive and specific biomarker for cigarette smoking</article-title><source>Biomarkers</source><year>2014</year><volume>19</volume><issue>6</issue><fpage>457</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.3109/1354750X.2014.935956</pub-id><pub-id pub-id-type="pmid">24980250</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newby</surname><given-names>DE</given-names></name><name name-style="western"><surname>Mannucci</surname><given-names>PM</given-names></name><name name-style="western"><surname>Tell</surname><given-names>GS</given-names></name><name name-style="western"><surname>Baccarelli</surname><given-names>AA</given-names></name><name name-style="western"><surname>Brook</surname><given-names>RD</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K</given-names></name><etal/></person-group><article-title>Expert position paper on air pollution and cardiovascular disease</article-title><source>Eur Heart J</source><year>2015</year><volume>36</volume><issue>2</issue><fpage>83</fpage><lpage>93b</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehu458</pub-id><pub-id pub-id-type="pmid">25492627</pub-id><pub-id pub-id-type="pmcid">PMC6279152</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wesselink</surname><given-names>AK</given-names></name><name name-style="western"><surname>Carwile</surname><given-names>JL</given-names></name><name name-style="western"><surname>Fabian</surname><given-names>MP</given-names></name><name name-style="western"><surname>Winter</surname><given-names>MR</given-names></name><name name-style="western"><surname>Butler</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Mahalingaiah</surname><given-names>S</given-names></name><etal/></person-group><article-title>Residential proximity to roadways and ischemic placental disease in a Cape Cod Family Health Study</article-title><source>Int J Environ Res Public Health</source><year>2017</year><volume>14</volume><issue>7</issue><fpage>682</fpage><pub-id pub-id-type="doi">10.3390/ijerph14070682</pub-id><pub-id pub-id-type="pmid">28672786</pub-id><pub-id pub-id-type="pmcid">PMC5551120</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abplanalp</surname><given-names>W</given-names></name><name name-style="western"><surname>DeJarnett</surname><given-names>N</given-names></name><name name-style="western"><surname>Riggs</surname><given-names>DW</given-names></name><name name-style="western"><surname>Conklin</surname><given-names>DJ</given-names></name><name name-style="western"><surname>McCracken</surname><given-names>JP</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>S</given-names></name><etal/></person-group><article-title>Benzene exposure is associated with cardiovascular disease risk</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>9</issue><fpage>e0183602</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0183602</pub-id><pub-id pub-id-type="pmid">28886060</pub-id><pub-id pub-id-type="pmcid">PMC5590846</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malovichko</surname><given-names>MV</given-names></name><name name-style="western"><surname>Abplanalp</surname><given-names>WT</given-names></name><name name-style="western"><surname>McFall</surname><given-names>SA</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>BS</given-names></name><name name-style="western"><surname>Wickramasinghe</surname><given-names>NS</given-names></name><name name-style="western"><surname>Sithu</surname><given-names>ID</given-names></name><etal/></person-group><article-title>Subclinical markers of cardiovascular toxicity of benzene inhalation in mice</article-title><source>Toxicol Appl Pharmacol</source><year>2021</year><volume>431</volume><fpage>115742</fpage><pub-id pub-id-type="doi">10.1016/j.taap.2021.115742</pub-id><pub-id pub-id-type="pmid">34624356</pub-id><pub-id pub-id-type="pmcid">PMC8647905</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGraw</surname><given-names>KE</given-names></name><name name-style="western"><surname>Riggs</surname><given-names>DW</given-names></name><name name-style="western"><surname>Rai</surname><given-names>S</given-names></name><name name-style="western"><surname>Navas-Acien</surname><given-names>A</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lorkiewicz</surname><given-names>P</given-names></name><etal/></person-group><article-title>Exposure to volatile organic compounds - acrolein, 1,3-butadiene, and crotonaldehyde - is associated with vascular dysfunction</article-title><source>Environ Res</source><year>2021</year><volume>196</volume><fpage>110903</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2021.110903</pub-id><pub-id pub-id-type="pmid">33636185</pub-id><pub-id pub-id-type="pmcid">PMC8119348</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Lin LY, Chuang HC, Liu IJ, Chen HW, Chuang KJ. Reducing indoor air pollution by air conditioning is associated with improvements in cardiovascular health among the general population. Sci Total Environ. 2013; 463&#8211;4:176&#8211;81.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2013.05.093</pub-id><pub-id pub-id-type="pmid">23803502</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuang</surname><given-names>HC</given-names></name><name name-style="western"><surname>Ho</surname><given-names>KF</given-names></name><name name-style="western"><surname>Lin</surname><given-names>LY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Hong</surname><given-names>GB</given-names></name><name name-style="western"><surname>Ma</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Long-term indoor air conditioner filtration and cardiovascular health: a randomized crossover intervention study</article-title><source>Environ Int</source><year>2017</year><volume>106</volume><fpage>91</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2017.06.008</pub-id><pub-id pub-id-type="pmid">28624750</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>I</given-names></name><name name-style="western"><surname>Park</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>J</given-names></name><etal/></person-group><article-title>Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds is associated with a risk of obesity and diabetes mellitus among Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015&#8211;2017</article-title><source>Int J Hyg Environ Health</source><year>2022</year><volume>240</volume><fpage>113886</fpage><pub-id pub-id-type="doi">10.1016/j.ijheh.2021.113886</pub-id><pub-id pub-id-type="pmid">34864598</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shim</surname><given-names>YH</given-names></name><name name-style="western"><surname>Ock</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D</given-names></name></person-group><article-title>Association between Heavy Metals, Bisphenol A, Volatile Organic compounds and phthalates and metabolic syndrome</article-title><source>Int J Environ Res Public Health</source><year>2019</year><volume>16</volume><issue>4</issue><fpage>671</fpage><pub-id pub-id-type="doi">10.3390/ijerph16040671</pub-id><pub-id pub-id-type="pmid">30823556</pub-id><pub-id pub-id-type="pmcid">PMC6406723</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alg</surname><given-names>VS</given-names></name><name name-style="western"><surname>Sofat</surname><given-names>R</given-names></name><name name-style="western"><surname>Houlden</surname><given-names>H</given-names></name><name name-style="western"><surname>Werring</surname><given-names>DJ</given-names></name></person-group><article-title>Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals</article-title><source>Neurology</source><year>2013</year><volume>80</volume><issue>23</issue><fpage>2154</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318295d751</pub-id><pub-id pub-id-type="pmid">23733552</pub-id><pub-id pub-id-type="pmcid">PMC3716358</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakaoka</surname><given-names>H</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Akiyama</surname><given-names>K</given-names></name><name name-style="western"><surname>Cui</surname><given-names>T</given-names></name><name name-style="western"><surname>Tajima</surname><given-names>A</given-names></name><name name-style="western"><surname>Krischek</surname><given-names>B</given-names></name><etal/></person-group><article-title>Differential effects of chromosome 9p21 variation on subphenotypes of intracranial aneurysm: site distribution</article-title><source>Stroke</source><year>2010</year><volume>41</volume><issue>8</issue><fpage>1593</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.110.586529</pub-id><pub-id pub-id-type="pmid">20595659</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>